期刊文献+

建立一种survivin抗原肽诱导T淋巴细胞优势取用TCR Vβ基因的方法

Establishment of a method in which the specificity TCR Vβ gene amplification was induced in survivin antigen peptide-stimulated T lymphocyte
下载PDF
导出
摘要 目的:探讨survivin抗原肽体外诱导健康人外周血单个核细胞(PBMC)后T淋巴细胞活化情况及TCRVβ表达谱变化。方法:分离健康人PBMC经rhIL-4、rhGM-CSF诱导DCs,将成熟DCs分为阴性组(不负载肽)、未洗脱负载组(负载survivin肽)、洗脱负载组(经酸液洗脱并多聚甲醛固定后负载survivin肽),分别与自体淋巴细胞共培养诱导抗原特异性T淋巴细胞。分别于24小时、48小时、96小时和7天以Elisa法检测诱导后T淋巴细胞中IFN-γ的分泌,并于第7天通过流式细胞仪分析TCRVβ表达谱。结果:随着时间延长两实验组IFN-γ的分泌比阴性组显著增高,且洗脱负载组增加更为显著。流式细胞仪分析结果显示洗脱负载组相比于阴性组及未洗脱负载组引起TCR Vβ表达谱的改变更为明显,其中TCR亚家族Vβ7.2、Vβ12、Vβ14、Vβ16、Vβ20、Vβ22最为显著。结论:DCs经酸液洗脱表面多肽并固定的方法更能有效地诱导TCRVβ亚家族优势取用。 Objective:To investigate T lymphocyte' s activation and TCR Vβ expression profile changes after the health human peripheral blood mononuclear cells (PBMC) were induced by survivin antigen peptide in vitro . Methods:PBMC were isolated from healthy donors and DCs was induced by IL-4, rhGM-CSF . Mature DCs were divided into 3 groups,including negative group (without loaded peptide group, NG), loaded group without eluted and fixed( louded peptide without the acid eluted and paraformaldehyde fixed group, LG), and loaded group with eluted and fixed( louded peptide with the acid eluted and paraformaldehyde fixed group,E + LG), which were co-cultured with autologous lymphocytes to induce antigen-specific T lymphocytes respectively. The IFN-γsecretion levels of induced T lymphocytes were detected by ELISA at different time-points. The changes of TCR Vβ expression were analyzed at Dayγ by flow cytometry. Results:Compared with the control group, the experimental group's secretion of IFN-γ increased significantly with time. Flow cytometric analysis showed that the expressions of TCR Vβ subfamily were changed significantly in E + L group rather than other two groups, which included Vβ3, Vβ7.2, Vβ12, Vβ14, Vβ16, Vβ20, Vβ22 subfamilies. Conclusion:After using the acid e- luted and paraformaldehyde fixed, peptie-loaded DC can induce TCR Vβ subfamily advantage of T lymphocyte cell more effectively.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2013年第3期300-303,共4页 Chinese Journal of Immunology
基金 国家"重大新药创制"科技重大专项(2009ZX09103-708) 国家自然科学基金(31100664) 广东省自然科学基金(1015102240100002)
关键词 SURVIVIN DC负载抗原 TCR Vβ表达谱 survivin DC load antigen TCR Vβ repertoire
  • 相关文献

参考文献13

  • 1Toshiki Ochi, Hiroshi Fujiwara, Masaki Yasukawa. Application of a- doptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia[ J]. J Biomed Bio- technol,2010 ; Article ID 521248 : 1-11. 被引量:1
  • 2Carl H. June. Adoptive T cell therapy for cancer in the clinic[J]. J Clin Invest,2007 ; 117 (6) : 1466-1476. 被引量:1
  • 3Renkvist N, Castelli C, Robbins P F et al. A listing of human tumor antigens recognized by T cells [ J]. Cancer Immunol Immunother, 2001 ;50( 1 ) :3-15. 被引量:1
  • 4杨静,钟森.Survivin与肝癌关系的研究进展[J].国际消化病杂志,2007,27(4):269-270. 被引量:2
  • 5孙裕昌,沈娟,沈晗,邵红伟,黄树林.Hela细胞Survivin克隆及HLA-A2限制性CTL表位预测研究[J].中国免疫学杂志,2007,23(11):1044-1047. 被引量:2
  • 6Schoell W M, Mirhashemi R, Liu Bet al. Generation of tumor-spe- cific cytotoxic T lymphocytes by stimulation with HPV type 16E7 pep- tide-pulsed dendritic cells:an approach to immunotherapy of cervical cancer[ J]. Gynecol Oncol, 1999 ;74(3) :448-455. 被引量:1
  • 7陈维春,林月霞,黄树林,周继斌,罗利琼.识别肝癌抗原的TCRVβ7亚家族克隆转基因后的生物学作用[J].中国免疫学杂志,2001,17(3):138-141. 被引量:5
  • 8Yan Tang, Zhihua Lin,Bing Ni et al. An altered peptide ligand for nave cytotoxic T lymphocyte epitope of TRP-2 ( 180-188 ) enhanced immunogenicity [ J ]. Cancer Immunol Immunorther, 2007 ; 56 : 319-329. 被引量:1
  • 9张怡,王庆余.HL60细胞抗原多肽的提取和质量观察[J].第三军医大学学报,2002,24(7):863-864. 被引量:2
  • 10Ziegler K, Unanue E R. Identification of a macrophage antigen-pro- cessing event requied for 1-region-restricted antigen presentation to T lymphocytes [ J ]. J Immunol, 1981 ; 127 (5) : 1869-1875. 被引量:1

二级参考文献45

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部